An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma
Clinical trial NCT02143999 · COMPLETED
Trial details
- NCT number
- NCT02143999
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-27
- Primary completion
- 2016-12-30
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.